These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15332692

  • 1. Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.
    Ruffin CG, Busch BE.
    Am J Health Syst Pharm; 2004 Jul 15; 61(14):1449-59. PubMed ID: 15332692
    [Abstract] [Full Text] [Related]

  • 2. Spotlight on omalizumab in allergic asthma.
    Bang LM, Plosker GL.
    BioDrugs; 2004 Jul 15; 18(6):415-8. PubMed ID: 15571425
    [Abstract] [Full Text] [Related]

  • 3. Omalizumab: a review of its use in the management of allergic asthma.
    Bang LM, Plosker GL.
    Treat Respir Med; 2004 Jul 15; 3(3):183-99. PubMed ID: 15219177
    [Abstract] [Full Text] [Related]

  • 4. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.
    D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov 15; 1(3):225-31. PubMed ID: 19075985
    [Abstract] [Full Text] [Related]

  • 5. Anti-IgE for chronic asthma in adults and children.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2004 Nov 15; (3):CD003559. PubMed ID: 15266491
    [Abstract] [Full Text] [Related]

  • 6. Anti-IgE for chronic asthma in adults and children.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003559. PubMed ID: 16625585
    [Abstract] [Full Text] [Related]

  • 7. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma.
    Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF.
    J Allergy Clin Immunol; 2009 Dec 19; 124(6):1210-6. PubMed ID: 19910033
    [Abstract] [Full Text] [Related]

  • 8. Anti-IgE for chronic asthma.
    Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.
    Cochrane Database Syst Rev; 2003 Dec 19; (3):CD003559. PubMed ID: 12917972
    [Abstract] [Full Text] [Related]

  • 9. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).
    Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.
    Pediatrics; 2001 Aug 19; 108(2):E36. PubMed ID: 11483846
    [Abstract] [Full Text] [Related]

  • 10. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002 Aug 19; 16(5):380-6. PubMed ID: 12408744
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.
    Kulus M, Hébert J, Garcia E, Fowler Taylor A, Fernandez Vidaurre C, Blogg M.
    Curr Med Res Opin; 2010 Jun 19; 26(6):1285-93. PubMed ID: 20377320
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of omalizumab from a health plan perspective.
    Belliveau PP, Lahoz MR.
    J Manag Care Pharm; 2005 Jun 19; 11(9):735-45. PubMed ID: 16300417
    [Abstract] [Full Text] [Related]

  • 14. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.
    Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G.
    Eur Respir J; 2001 Aug 19; 18(2):254-61. PubMed ID: 11529281
    [Abstract] [Full Text] [Related]

  • 15. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.
    J Allergy Clin Immunol; 2001 Aug 19; 108(2):184-90. PubMed ID: 11496232
    [Abstract] [Full Text] [Related]

  • 16. Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.
    D'Amato G, Perticone M, Bucchioni E, Salzillo A, D'Amato M, Liccardi G.
    Eur Ann Allergy Clin Immunol; 2010 Aug 19; 42(4):135-40. PubMed ID: 21114196
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma.
    Berger W, Gupta N, McAlary M, Fowler-Taylor A.
    Ann Allergy Asthma Immunol; 2003 Aug 19; 91(2):182-8. PubMed ID: 12952113
    [Abstract] [Full Text] [Related]

  • 18. Treating Moderate-to-Severe Allergic Asthma with a Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab).
    D'Amato G, Bucchioni E, Oldani V, Canonica W.
    Treat Respir Med; 2006 Aug 19; 5(6):393-8. PubMed ID: 17154668
    [Abstract] [Full Text] [Related]

  • 19. Omalizumab: a review of its use in the treatment of allergic asthma.
    Plosker GL, Keam SJ.
    BioDrugs; 2008 Aug 19; 22(3):189-204. PubMed ID: 18481901
    [Abstract] [Full Text] [Related]

  • 20. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep 19; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.